BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $10,281,000 | +16.9% | 100,000 | 0.0% | 0.23% | +28.5% |
Q2 2021 | $8,796,000 | -79.5% | 100,000 | -81.8% | 0.18% | -85.1% |
Q2 2020 | $42,900,000 | +22.3% | 550,000 | -8.3% | 1.20% | -19.1% |
Q1 2020 | $35,088,000 | -12.4% | 600,000 | +20.0% | 1.48% | -4.1% |
Q4 2019 | $40,055,000 | -9.1% | 500,000 | -16.7% | 1.55% | -12.5% |
Q3 2019 | $44,082,000 | -37.7% | 600,000 | -20.0% | 1.77% | -38.2% |
Q2 2019 | $70,748,000 | +4.0% | 750,000 | -11.8% | 2.86% | +3.0% |
Q1 2019 | $68,043,000 | +110.4% | 850,000 | +41.7% | 2.78% | +131.9% |
Q4 2018 | $32,346,000 | -17.1% | 600,000 | +20.0% | 1.20% | +18.0% |
Q3 2018 | $39,030,000 | -31.7% | 500,000 | -44.4% | 1.02% | -16.4% |
Q2 2018 | $57,132,000 | +24.6% | 900,000 | +80.0% | 1.21% | +111.9% |
Q1 2018 | $45,850,000 | +508.0% | 500,000 | +400.0% | 0.57% | +402.6% |
Q4 2017 | $7,541,000 | – | 100,000 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
SIB LLC | 65,151 | $6,335,000 | 3.72% |
CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |